Dr. Bazhenova on Potential Impact of Immunotherapy in Non-Driver NSCLC

Evolving ParadigmsNon-Small Cell Lung Cancer
Volume 1
Issue 1

Lyudmila A. Bazhenova, MD, medical oncologist, professor of medicine, UC San Diego Health, discusses what potential impact immunotherapy agents could have on outcomes for patients with non-driver non–small cell lung cancer.

Related Videos
Expert on NSCLC
Expert on NSCLC
Expert on NSCLC
Experts on NSCLC